Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...

Every 15 minutes, someone in the U.S. dies from a drug-resistant superbug. A few decades from now, antibiotic-resistant bacterial infections threaten to become the leading cause of death worldwide, ...

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical ...

Modern-day HIV treatments may stem from a genetic mutation dating back to the Viking Age, researchers said. Steinar Engeland via Unsplash On June 5, 1981, the Centers for Disease Control and ...

M184V/I emerged as the dominant NRTI resistance mutation across the continents represented in the review. The clinical ...

In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...